Kuipers F, Derksen J P, Gerding A, Scherphof G L, Vonk R J
Department of Pediatrics, University of Groningen, The Netherlands.
Biochim Biophys Acta. 1987 Nov 21;922(2):136-44. doi: 10.1016/0005-2760(87)90147-0.
Glycolithocholic acid and its sulfated derivative are major metabolites of the secondary bile acid lithocholic acid in man. Both compounds are known to induce cholestasis in experimental animals. We compared the effects of these endogenous hepatotoxins on bile production and biliary lipid composition in rats with chronic biliary drainage. The compounds were administered enterally at relatively low rates (5-50% of the rats' endogenous bile acid secretion in these experiments) to simulate enterohepatic circulation. Both compounds were substantially secreted into bile (more than 90% of dose); sulfated glycolithocholic acid unchanged and glycolithocholic acid after hepatic hydroxylation predominantly in the form of glyco-beta-muricholic acid (cf. Kuipers et al. (1986) Am. J. Physiol. 251, G189-G194). Neither glycolithocholic acid nor its sulfated derivative affected the biliary excretion of endogenous bile acids or bile flow in these experiments. In spite of this, phospholipid and cholesterol secretion were significantly reduced by sulfated glycolithocholic acid but were not altered by glycolithocholic acid. Phospholipid and cholesterol secretion rapidly decreased to 25 and 50% of their initial values, respectively, at biliary output rates of sulfated glycolithocholic acid up to 2 mumol/h, and did not further decrease when this output was increased to 6 mumol/h. Small unilamellar liposomes consisting of cholesterol, [Me-14C]choline-labeled phosphatidylcholine, phosphatidylserine and [3H]cholesteryl oleate in a 5:4:1:0.1 molar ratio were employed to label intrahepatic lipid pools. Administration of sulfated glycolithocholic acid slightly reduced bile acid synthesis from [3H]cholesteryl oleate, but significantly reduced the biliary secretion of [14C]phospholipid. Glycolithocholic acid did not affect the hepatic processing of liposomal lipids. It is concluded that sulfated glycolithocholic acid at low doses causes the uncoupling of biliary lipid secretion from that of bile acids, which might represent in initiating event in sulfated glycolithocholic acid hepatotoxicity.
甘氨石胆酸及其硫酸化衍生物是人体内次级胆汁酸石胆酸的主要代谢产物。已知这两种化合物均可在实验动物中诱发胆汁淤积。我们比较了这些内源性肝毒素对慢性胆汁引流大鼠胆汁生成和胆汁脂质成分的影响。以相对较低的速率(在这些实验中为大鼠内源性胆汁酸分泌量的5 - 50%)经肠道给予这些化合物,以模拟肝肠循环。两种化合物均大量分泌入胆汁(超过剂量的90%);硫酸化甘氨石胆酸未发生变化,而甘氨石胆酸在肝脏羟化后主要以甘氨-β-鼠胆酸的形式存在(参见Kuipers等人(1986年)《美国生理学杂志》251卷,G189 - G194页)。在这些实验中,甘氨石胆酸及其硫酸化衍生物均未影响内源性胆汁酸的胆汁排泄或胆汁流量。尽管如此,硫酸化甘氨石胆酸可显著降低磷脂和胆固醇的分泌,但甘氨石胆酸对此无影响。在硫酸化甘氨石胆酸的胆汁输出速率高达2 μmol/h时,磷脂和胆固醇的分泌迅速分别降至其初始值的25%和50%,当该输出量增加至6 μmol/h时,分泌量不再进一步降低。由胆固醇、[甲基-14C]胆碱标记的磷脂酰胆碱、磷脂酰丝氨酸和[3H]胆固醇油酸酯按5:4:1:0.1的摩尔比组成的小单层脂质体用于标记肝内脂质池。给予硫酸化甘氨石胆酸可略微降低[3H]胆固醇油酸酯合成胆汁酸的量,但显著降低[14C]磷脂的胆汁分泌。甘氨石胆酸不影响脂质体脂质的肝脏处理过程。得出的结论是,低剂量的硫酸化甘氨石胆酸会导致胆汁脂质分泌与胆汁酸分泌解偶联,这可能是硫酸化甘氨石胆酸肝毒性的起始事件。